Dr. John Oertle of Envita Medical Centers Speaks on World Lung Cancer Day by AZ Family
Lung cancer is the leading cause of cancer death in the United States, claiming nearly 370 lives every day, but advanced screening and early intervention can play a crucial role in checking cancer deaths. “When you catch it early, it's actually quite good,” said Dr. John Oertle, Chief Medical Director, Envita Medical Centers, referring to life expectancy after a lung cancer diagnosis.
Even when doctors suspect it, its testing may show false negatives, highlighting the need for detailed diagnostics and an experienced clinical eye. Dr. Warren's team at Envita has over two decades of clinical experience in successfully treating patients with Lyme disease complex, many of whom were manifesting symptoms for years or decades.
He explained how his team at Envita Medical Centers utilizes the latest technologies such as cryotherapy and advanced personalized immunotherapies to help patients progress towards a holistic recovery. Team Envita has over two decades of clinical experience in treating patients with late-stage cancers, many of whom were left with limited options at other cancer treatment facilities. Utilization of the advanced personalized precision oncology approach enables the specially trained team at Envita to strike at the root causes of each patient's disease, while reactivating their immune system concurrently, which is crucial for lasting outcomes.
Like other cancers, even lung cancer has a better prognosis if the disease is caught and treated early, but unfortunately only 18% of lung cancer cases are caught in the early stages. Emphasizing on the need for being aware of one's symptoms and seeking early intervention, Dr. Oertle mentioned that if patients notice symptoms like persistent coughing, coupled with a history of smoking or family history of lung cancer, they should seek help at the earliest opportunity. He said that low dose CT scans and advanced biometric screenings may serve as crucial tools in screening and early identification of lung cancers.
The Envita team is utilizing innovative healthcare technologies to not just screen lung cancers, but many other types of cancers, and they are striving towards helping every American gain access to such advanced screening tools through their employer sponsored health plans. To know more about Envita's advanced approach in treating and preventing lung cancer and other cancers, watch this interview here.
